Faecal microbiota transplantation (FMT) has emerged as a remarkably successful treatment
for recurrent Clostridioides difficile infection that cannot be cured with antibiotics alone …

Clostridioides difficile infection (CDI) is one of the major issues in nosocomial infections.
This bacterium is constantly evolving and poses complex challenges for clinicians, often …

Triptolide (TP), a traditional Chinese medicine, has been reported to be effective in the
treatment of autoimmune diseases and exerting antineoplastic activity in several human …

Clostridioides difficile infection (CDI) represents a significant challenge to public health. C.
difficile-associated mortality and morbidity have led the US CDC to designate it as an urgent …

Clostridium (reclassified as “Clostridioides”) difficile infection (CDI) is a healthcare-
associated infection and significant source of potentially preventable morbidity, recurrence …

Introduction: Coxiella burnetii infection is still challenging physicians, mainly because no
international coordination has been stated to standardize the therapeutic strategy and …

Since the discovery of Clostridium difficile infection (CDI) in the 1970s, there has been an
increase in the incidence, severity, and recurrence rate of the disease. We reviewed the …

Clostridium difficile is a gram-positive, spore forming anaerobe that infects the gut when the
normal microbiota has been disrupted. C. difficile infection (CDI) is the most common cause …

Clostridium difficile infection (CDI) is the most common cause of antibiotic-associated
diarrhea and a significant burden on the health care system. Aging has been identified in the …

With current first-in-line antibiotic therapy options associated with high levels of recurrent
CDI, the availability of new generation targeted therapeutics can really impact treatment …